JESSICA OAKS: Open Payments
NPI 1932285285 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$159 in 6 payments from 6 companies in 2025. Trend: 2023 $137 · 2024 $397 · 2025 $159
Food & beverage: $159
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 1 | $41 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| SCPHARMACEUTICALS INC. | 1 | $22 |
| Lundbeck LLC | 1 | $22 |
| Kestra Medical Technology Services, Inc. | 1 | $22 |
Products named: OPSUMIT, KESIMPTA, VERQUVO, FUROSCIX, VYEPTI, Assure WCD.
Industry payments across MI — which companies pay providers there.
